[HTML][HTML] The Role of Non-Invasive Brain Modulation in Identifying Disease Biomarkers for Diagnostic and Therapeutic Purposes in Parkinsonism

D Birreci, M De Riggi, D Costa, L Angelini… - Brain Sciences, 2024 - mdpi.com
Over the past three decades, substantial advancements have occurred in non-invasive brain
stimulation (NIBS). These developments encompass various non-invasive techniques aimed …

Advanced therapies in Parkinson's disease: an individualized approach to their indication

N Schröter, BEA Sajonz, WH Jost, M Rijntjes… - Journal of Neural …, 2024 - Springer
Device aided therapies (DAT) comprising the intrajejunal administration of
levodopa/carbidopa intestinal gel (LCIG) and levodopa/carbidopa/entacapone intestinal gel …

Levodopa–Entacapone–Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson's Disease: A Single Center Real-World Experience

S Szatmári, JA Szász, K Orbán-Kis, B Baróti, S Bataga… - Pharmaceutics, 2024 - mdpi.com
Levodopa–entacapone–carbidopa intestinal gel infusion is a relatively new treatment option
for advanced Parkinson's disease. We aimed to describe and analyze the characteristics of …

The akinetic crisis in Parkinson´ s disease-the upper end of a spectrum of subacute akinetic states

M Pötter-Nerger, C Schrader, WH Jost… - Journal of Neural …, 2024 - Springer
The akinetic crisis is defined as an acute, potentially life-threatening, levodopa-resistant,
severe aggravation of rigidity, severe akinesia, associated with high fever, disturbance of …

James Parkinson and Other Historical Aspects of Parkinson's Disease

HL Dainton-Howard, CG Goetz - Neurologic Clinics, 2025 - neurologic.theclinics.com
In 1817, James Parkinson published An Essay on the Shaking Palsy, the landmark paper
that describes what we now call Parkinson's disease (PD). Using analysis of previous …

Synergien statt Rivalitäten–die missverstandenen Rollen von kontinuierlicher intrajejunaler Levodopatherapie und Tiefer Hirnstimulation in der Behandlung des …

N Schröter, WH Jost, M Rijntjes… - Fortschritte der …, 2024 - thieme-connect.com
In der Therapie des Morbus Parkinson kommen sowohl die intrajejunale Applikation von
Levodopa/Carbidopa Intenstinalgel (LCIG) und seit kurzem Levodpoa/Carbidopa …

Noninvasive Therapies: A Forthcoming Approach to Parkinson's Treatment

U Anayyat, F Ahad, BM Fordil, H Hameed… - CNS & Neurological …, 2025 - benthamdirect.com
In this review, we have discussed the invasive and non-invasive treatment options for
Parkinson's Disease (PD) following their safety, specificity, and reliability. Initially, this study …

Előrehaladott Parkinson-kóros betegek kezelése levodopa-entakapon-karbidopa intestinalis géllel: az első két év tapasztalata

S Szatmári, JA Szász, V Constantin, I Mihály… - Orvosi …, 2025 - akjournals.com
Bevezetés: Előrehaladott Parkinson-kórban az oralisan, illetve transdermalisan adagolt
dopaminerg szerek már nem elég hatékonyak, és jelentős mellékhatással bírnak, ezért …

[HTML][HTML] Subthalamic Deep Brain Stimulation in Advanced Parkinson's Disease

M Koivu - 2024 - helda.helsinki.fi
Parkinson's disease causes both motor and non-motor symptoms. These may be alleviated
with dopaminergic medication, but over time, motor and non-motor complications such as …

Therapieansätze für das fortgeschrittene idiopathische Parkinson-Syndrom: Kontinuierliche dopaminerge Stimulationsverfahren im Überblick

E Berberovic, W H. Jost - DNP–Die Neurologie & Psychiatrie, 2023 - Springer
Das idiopathische Parkinson-Syndrom ist die häufigste neurodegenerative
Bewegungsstörung. Unbehandelt beeinträchtigt es die Lebensqualität erheblich …